Detalles de la búsqueda
1.
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10382): 1079-1090, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868261
2.
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10328): 945-955, 2022 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35219377
3.
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
Allergy Asthma Proc
; 43(3): 202-208, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524357
4.
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
N Engl J Med
; 376(12): 1131-1140, 2017 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28328347
5.
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema.
Ann Allergy Asthma Immunol
; 125(3): 334-340.e1, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445670
6.
Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
Allergy Asthma Proc
; 39(5): 365-370, 2018 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30107868
7.
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Ann Allergy Asthma Immunol
; 117(5): 508-513, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27788880
8.
Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.
Allergy Asthma Proc
; 36(3): 218-24, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25803207
9.
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.
Lancet Haematol
; 11(6): e436-e447, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710185
10.
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry.
Ann Allergy Asthma Immunol
; 118(1): 110-112, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27865714
11.
A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab.
Clin Transl Sci
; 15(3): 626-637, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34859955
12.
Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema.
Pediatr Allergy Immunol Pulmonol
; 33(3): 136-141, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32953229
13.
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.
Allergy Asthma Clin Immunol
; 16: 8, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32042283
14.
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study.
Allergy Asthma Clin Immunol
; 15: 49, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31485239
15.
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
J Allergy Clin Immunol Pract
; 7(6): 1793-1802.e2, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772477
16.
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.
Allergy Rhinol (Providence)
; 8(1): 13-19, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28381322
17.
Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.
Thromb Haemost
; 121(5): 690-693, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33202446
18.
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
J Allergy Clin Immunol Pract
; 4(5): 963-71, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27286778
19.
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings.
J Allergy Clin Immunol Pract
; 7(6): 2035-2038, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30660873
20.
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
J Allergy Clin Immunol Pract
; 5(4): 1142-1145, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28286153